Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Goossens, HermanFerech, Matus
Vander Stichele, Robert
Elseviers, Monique
ESAC Project Group (including Kristinsson KG)
Útgáfudagur
2006-06-07T15:45:48Z
Metadata
Show full item recordCitation
Lancet 2005, 365(9459):579-87Útdráttur
BACKGROUND: Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly recognised as the main selective pressure driving this resistance. Our aim was to assess outpatient use of antibiotics and the association with resistance. METHODS: We investigated outpatient antibiotic use in 26 countries in Europe that provided internationally comparable distribution or reimbursement data, between Jan 1, 1997, and Dec 31, 2002, by calculating the number of defined daily doses (DDD) per 1000 inhabitants per day, according to WHO anatomic therapeutic chemical classification and DDD measurement methodology. We assessed the ecological association between antibiotic use and antibiotic resistance rates using Spearman's correlation coefficients. FINDINGS: Prescription of antibiotics in primary care in Europe varied greatly; the highest rate was in France (32.2 DDD per 1000 inhabitants daily) and the lowest was in the Netherlands (10.0 DDD per 1000 inhabitants daily). We noted a shift from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. We also recorded striking seasonal fluctuations with heightened winter peaks in countries with high yearly use of antibiotics. We showed higher rates of antibiotic resistance in high consuming countries, probably related to the higher consumption in southern and eastern Europe than in northern Europe. INTERPRETATION: These data might provide a useful method for assessing public-health strategies that aim to reduce antibiotic use and resistance levels.Lu00FDsing
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldVefslóð
http://www.sciencedirect.com/science/article/B6T1B-4FFX4C2-15/2/9561b1cbc8062ea8be8df0d77a4d27cdae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(05)17907-0
Scopus Count
Collections
Related articles
- Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
- Authors: Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y, Study Group participants.
- Issue date: 2013 Jan
- Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations.
- Authors: Elseviers MM, Ferech M, Vander Stichele RH, Goossens H, ESAC project group.
- Issue date: 2007 Jan
- Antibiotic policies in Central Eastern Europe.
- Authors: Cizman M, Beovic B, Krcmery V, Barsic B, Tamm E, Ludwig E, Pelemis M, Karovski K, Grzesiowski P, Gardovska D, Volokha A, Keuleyan E, Stratchounski L, Dumitru C, Titov LP, Usonis V, Dvorák P
- Issue date: 2004 Sep
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
- Authors: Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H, ESAC Project Group.
- Issue date: 2006 Aug
- Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis.
- Authors: Minalu G, Aerts M, Coenen S, Versporten A, Muller A, Adriaenssens N, Beutels P, Molenberghs G, Goossens H, Hens N
- Issue date: 2011 Dec